Puneet Arora is the CMO of Lassen. Puneet is a highly regarded physician-scientist and drug developer with more than a decade of experience in the development of innovative investigational therapies and clinical leadership in small and large biotech companies. He most recently served as Head of Clinical, Inflammation and Immunology at Principia Biopharma, a Sanofi company. At Principia, he led clinical development strategy and the clinical team in the design and execution of clinical studies across the company’s portfolio. Puneet managed clinical development for lead programs including early translational development and proof of concept through late development and regulatory submissions. He played a key role in leading the pivotal study clinical and filing teams for the rilzabrutinib program in pemphigus. Prior to his time at Principia, he was Senior Medical Director of Early Clinical Development and Clinical Team Leader at Genentech Research and Early Development working across multiple therapeutic areas. He also worked at Amgen, leading clinical teams for the development of romosozumab (early stage) and denosumab (late stage). Puneet received his medical degree from the All India Institute of Medical Sciences, completed his residency in internal medicine at the Southern Illinois University School of Medicine, a fellowship in endocrinology at NYU, and a Master’s Degree in Clinical Research and fellowship in Advanced Diabetology at the Mayo Clinic, as part of the Clinical Research Training Program. He is also an alumnus of the American Course on Drug Development and Regulatory Sciences (UCSF).
